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Background: Non-speciﬁc chest symptoms associated with coronary artery spasm
(CAS) remain underdiagnosed and consequently undertreated. Our center applies
a policy of systematic CAS detection by provocative tests (PT) in normal or near
normal coronary arteries in patients with symptoms compatible with vasospastic
origin. We retrospectively studied the prevalence of CAS, safety of PTs and patient
outcome over a 10-year period.
Methods: From December 2002 to July 2012, 13,902 patients underwent 18,454
coronary angiographies. 5,962 of these patients with normal or near normal arteries
underwent 2,397 PTs. 256 were consequently diagnosed with CAS (10.7%). In
addition, among the 7,940 patients with a 50% stenosis on coronary angiography, 44
patients were diagnosed as having a spontaneous CAS (0.6%).
Results: Compared to the overall population, patients with CAS were more often
female (44.7% vs. 29.6%; p<0.0001), younger (55 [47.5-64] years vs. 61 [52-70]
years; p¼0.0001), and more often smokers (63.7% vs. 42.3%; p<0.0001). Initial
presentation was more frequently acute coronary syndrome (37.4% vs. 28.9%) and
non-speciﬁc chest pain (41.8% vs. 21.6%). Sixty-nine patients had refractory CAS
when PT was abnormal under antispastic treatment. 99.1% of the patients who
underwent a PT had an event-free hospital course. At 46 months, the all-cause death
rate, myocardial infarction, stroke and revascularization in CAS patients were 4.3%,
3.3%, 0% and 4.3%, respectively.
Conclusions: This retrospective study of 10 years of experience suggests that CAS is
present in as many as 10.7% of patients with chest symptoms at rest. PT seems to be
safe in patients with normal or near normal coronary angiography. These ﬁndings
could justify performing PTs more systematically in this setting to avoid the poten-
tially severe outcomes of undiagnosed CAS.
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Background: Deferral of revascularization of an intermediate coronary stenosis with
fractional ﬂow reserve (FFR)S0.75 was reported to be safe. However, the FFR value
range between 0.75 and 0.80 has been recognized as a gray zone. We hypothesized
that outcomes after deferral of revascularization between coronary lesions with gray
zone FFR and those with non-ischemic FFR (>0.80) might be different. The aim of
this study was to evaluate the clinical outcomes of patients with intermediate coronary
stenosis with gray zone FFR compared to those with FFR >0.80.
Methods: We reviewed medical records of patients who underwent an FFR
measurement at our hospital between January 2008 and December 2011. Long-term
outcomes of 153 patients with angiographically intermediate coronary lesions deferred
from revascularization on the basis of an FFR > 0.75 were obtained. We divided the
patients into two groups. Gray zone group consisted of 57 patients with FFR values
between 0.75 to 0.80. Non-ischemia group comprised 96 patients with FFR values
above 0.80. The outcome of the gray zone group was compared with that of the non-
ischemia group. The primary endpoint of this study was target vessel failure (TVF)
deﬁned as cardiac death, target vessel related myocardial infarction, and ischemia-
driven target vessel revascularization.
Results: There were no differences in baseline clinical characteristics between two
groups. Mean FFR value of deferred lesions was signiﬁcantly lower in the gray zone
group than the non-ischemia group (0.78  0.02 vs. 0.88  0.05). During a mean
follow-up period of 2.8  1.2 years, TVF occurred in 11 deferred lesions (7.2%). The
incidence of TVF was signiﬁcantly different between two groups: 14.0% in the gray
zone group and 3.1% in the non-ischemia group (hazard ratio: 4.043, 95% conﬁdence
interval, 1.048 to 15.603; p ¼ 0.043).
Conclusions: Not all deferred lesions based on FFRS 0.75 were equally safe during
the follow up period. Patients with deferred coronary lesions with the gray zone FFR
had higher risk of TVF in the future than those with FFR >0.80.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-611
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Background: Previous studies have identiﬁed post-stent fractional ﬂow reserve (FFR)
>0.90 as a useful surrogate for favorable long-term clinical outcome after bare-metal
stent implantation. However, the prognostic value of post-stent FFR after drug-eluting
stent (DES) implantation remains undetermined.
Methods: For 156 DES implanted lesions, FFR measurement at maximum hyperemia
was performed after stent implantation. Follow-up angiography was scheduled between
6 and 12 months after index intervention. Angiography was also performed in the late
phase based on patient's clinical conditions and physician's decision. The relationship
between post-stent FFR and target lesion revascularization (TLR) was evaluated.
Results: A FFR value was signiﬁcantly increased by stent implantation from
0.690.12 to 0.880.06 (p<0.0001). A FFR value > 0.90 was achieved in 63
patients (40.3%). During follow-up, TLR occurred in 12 lesions (7.7%). There was no
signiﬁcant difference in post-stent FFR between lesions with or without TLR
(0.890.07 vs. 0.890.07; p¼0.86). After grading lesions to 5 categories according to
the post-stent FFR (0.75 to 0.80, 0.81 to 0.85, 0.86 to 0.90, 0.91 to 0.95, and 0.96 to
1.00), there was no signiﬁcant difference in the incidence of TLR among 5 categories
(18.8%, 3.1%, 4.4%, 8.8%, 10.3%; p¼0.32).
Conclusions: In patients who were treated with DES, post-stent FFR is not a predictor
of long-term adverse event.
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Background: STEMI patients who present with open culprit vessels have on average
better clinical outcome. Functional endothelium regulates platelet aggregation,
controls endogenous ﬁbrinolysis, and may play a crucial role for culprit vessel patency
in the setting of STEMI. Nevertheless, clinical data on the relation between endothelial
function and culprit vessel patency in STEMI patients are scarce.
Methods: This prospective cohort study included 61 STEMI patients, who had all
undergone primary percutaneous coronary intervention (PPCI). Four to six weeks
later, endothelial function was non-invasively assessed by use of the reactive hyper-
emia peripheral artery tonometry (RH-PAT) method.
Results: The RH-PAT index measured on average 1.890.57. In patients with patent
culprit vessels before PPCI (n¼26, 42.6%), endothelial function was signiﬁcantly
better than in patients with occluded culprit vessels (n¼35, 57.4%) (RH-PAT index
2.090.62 vs. 1.740.48; p<0.01). Compared to patients with normal endothelial
function, the quintile of patients with the most severe endothelial dysfunction had
a nine-fold higher risk of presenting with an occluded culprit vessel (OR 9.0, 95% CI
1.4-58.4). Logistic regression analysis revealed that this relation between endothelial
function and vessel patency became even stronger after adjustment for potential
confounders (adjusted OR 13.3, 95% CI 1.3-134.0).acts/POSTER/Physiologic Lesion Assessment B185
